Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3903 |  RLYB Rallybio Corporation - Common Stock | 16.99 USD | +0.35% | +1.19% | +1.13% | +2989.09% | 90.23 M USD | ||
| 3904 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 0.48 USD | +2.13% | -14.29% | -60.00% | -74.87% | 90.19 M USD | ||
| 3907 |  CLLS Cellectis S.A. - American Depositary Shares | 1.25 USD | -6.72% | -13.79% | -59.55% | -70.24% | 89.69 M USD | ||
| 3908 |  PYPD PolyPid Ltd. - Ordinary Shares | 4.90 USD | -1.01% | -10.75% | -5.77% | +49.39% | 89.20 M USD | ||
| 3912 |  ICCC ImmuCell Corporation - Common Stock | 9.75 USD | +0.62% | +1.35% | -0.91% | +42.96% | 88.55 M USD | ||
| 3914 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 0.71 USD | -6.58% | -13.41% | -33.02% | -66.19% | 88.39 M USD | ||
| 3926 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.90 USD | -4.26% | -2.17% | -9.09% | -55.00% | 85.58 M USD | ||
| 3927 |  NRXS Neuraxis, Inc. Common Stock | 6.80 USD | -0.58% | -6.21% | +20.14% | +25.23% | 85.39 M USD | ||
| 3940 |  CRDF Cardiff Oncology, Inc. - Common Stock | 1.06 USD | -2.75% | -12.40% | +0.95% | -55.46% | 82.46 M USD | ||
| 3945 |  PMN ProMIS Neurosciences Inc. - Common Shares | 9.15 USD | +0.33% | -3.38% | -33.16% | +1659.62% | 82.05 M USD | ||
| 3959 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.87 USD | -0.53% | -8.78% | -7.88% | -5.08% | 80.14 M USD | ||
| 3964 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.49 USD | -0.67% | -14.86% | +8.76% | +7.97% | 79.65 M USD | ||
| 3968 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.15 USD | +2.68% | -1.71% | -3.36% | -35.75% | 79.09 M USD | ||
| 3980 |  MNOV MediciNova, Inc. - Common Stock | 1.54 USD | -4.35% | -8.88% | -12.99% | +25.20% | 75.80 M USD | ||
| 3997 |  NTRB Nutriband Inc. - Common Stock | 6.05 USD | -10.50% | -18.90% | +5.03% | -14.79% | 73.54 M USD | ||
| 4002 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.39 USD | -2.80% | +4.51% | -0.71% | -34.43% | 72.95 M USD | ||
| 4017 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.18 USD | +0.97% | -13.64% | -17.39% | -30.56% | 71.81 M USD | ||
| 4020 |  CING Cingulate Inc. - Common Stock | 4.88 USD | +0.21% | +1.88% | -5.61% | -20.78% | 70.96 M USD | ||
| 4023 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.62 USD | -2.99% | -7.43% | -5.81% | -23.58% | 70.70 M USD | ||
| 4025 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.16 USD | 0.00% | -4.13% | -14.07% | -44.23% | 70.56 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |